Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-05-13 to 2022-05-23
Current total value of award: $2253.2
Description: 8509100063!TYPHOID VI POLYSACC